Polyplus-transfection

About:

Polyplus-transfection develops, markets and sells solutions for the delivery of nucleic acids in research, bioproduction and therapeutics.

Website: http://www.polyplus-transfection.com

Twitter/X: polyplus_transf

Top Investors: Crédit Mutuel Innovation, CIC Finance, Sudinnova

Description:

Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.

Total Funding Amount:

2.5M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Illkirch-graffenstaden, Alsace, France

Founded Date:

2001-01-01

Founders:

Anne Monjanel, Joelle Bloch, Patrick Metz, Paul Behr

Number of Employees:

11-50

Last Funding Date:

2011-01-11

IPO Status:

Private

Industries:

© 2025 bioDAO.ai